Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy

Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial

(2016) Paula Mulvenna et al.   LANCET

Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation

(2016) Denise Bernhardt et al.   LUNG CANCER

Re-irradiation in the treatment of patients with cerebral metastases of solid tumors: retrospective analysis

(2014) Maike Scharp et al.   Radiation Oncology

Outcomes After Whole Brain Reirradiation in Patients With Brain Metastases

(2011) Christina H. Son et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

(2011) Paul W. Sperduto et al.   JOURNAL OF CLINICAL ONCOLOGY

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

(2009) Paul W. Sperduto et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS